Literature DB >> 12968035

The copper toxicosis gene product Murr1 directly interacts with the Wilson disease protein.

Ting Y Tao1, Fengli Liu, Leo Klomp, Cisca Wijmenga, Jonathan D Gitlin.   

Abstract

Copper toxicosis in Bedlington terriers is an autosomal recessive disorder characterized by excessive hepatic copper accumulation in association with a marked decrease in biliary copper excretion. Recent genetic data have revealed that MURR1, a single copy gene on dog chromosome 10q26, is mutated in this disorder. This gene encodes a 190-amino acid open reading frame of unknown function that is highly conserved in vertebrate species. The Wilson disease protein is a copper transporting ATPase shown to play a critical role in biliary copper excretion. Here we demonstrate that the Wilson disease protein directly interacts with the human homologue of Murr1 in vitro and in vivo and that this interaction is mediated via the copper binding, amino terminus of this ATPase. Importantly, this interaction is specific for this copper transporter, a finding consistent with the observation that impaired copper homeostasis in affected terriers is confined to the liver. Our findings reveal involvement of Murr1 in the defined pathway of hepatic biliary copper excretion, suggest a potential mechanism for Murr1 function in this process, and provide biochemical evidence in support of the proposed role of the MURR1 gene in hepatic copper toxicosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12968035     DOI: 10.1074/jbc.C300391200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  54 in total

1.  A novel role for XIAP in copper homeostasis through regulation of MURR1.

Authors:  Ezra Burstein; Lakshmanan Ganesh; Robert D Dick; Bart van De Sluis; John C Wilkinson; Leo W J Klomp; Cisca Wijmenga; George J Brewer; Gary J Nabel; Colin S Duckett
Journal:  EMBO J       Date:  2003-12-18       Impact factor: 11.598

2.  Quantitative PCR method to detect a 13-kb deletion in the MURR1 gene associated with copper toxicosis and HIV-1 replication.

Authors:  Robert P Favier; Bart Spee; Louis C Penning; Bas Brinkhof; Jan Rothuizen
Journal:  Mamm Genome       Date:  2005-06       Impact factor: 2.957

3.  Distinct Wilson's disease mutations in ATP7B are associated with enhanced binding to COMMD1 and reduced stability of ATP7B.

Authors:  Prim de Bie; Bart van de Sluis; Ezra Burstein; Peter V E van de Berghe; Patricia Muller; Ruud Berger; Jonathan D Gitlin; Cisca Wijmenga; Leo W J Klomp
Journal:  Gastroenterology       Date:  2007-07-25       Impact factor: 22.682

4.  COMMD1 expression is controlled by critical residues that determine XIAP binding.

Authors:  Gabriel N Maine; Xicheng Mao; Patricia A Muller; Christine M Komarck; Leo W J Klomp; Ezra Burstein
Journal:  Biochem J       Date:  2009-01-15       Impact factor: 3.857

Review 5.  Classification and differential diagnosis of Wilson's disease.

Authors:  Wieland Hermann
Journal:  Ann Transl Med       Date:  2019-04

6.  From caveman companion to medical innovator: genomic insights into the origin and evolution of domestic dogs.

Authors:  Heidi G Parker; Samuel F Gilbert
Journal:  Adv Genomics Genet       Date:  2015-06-12

Review 7.  Molecular pathogenesis of Wilson and Menkes disease: correlation of mutations with molecular defects and disease phenotypes.

Authors:  P de Bie; P Muller; C Wijmenga; L W J Klomp
Journal:  J Med Genet       Date:  2007-08-23       Impact factor: 6.318

8.  On the toxicity of therapeutically used nanoparticles: an overview.

Authors:  A El-Ansary; S Al-Daihan
Journal:  J Toxicol       Date:  2009-01-25

9.  A novel COMMD1 mutation Thr174Met associated with elevated urinary copper and signs of enhanced apoptotic cell death in a Wilson Disease patient.

Authors:  Arnab Gupta; Ishita Chattopadhyay; Shashwata Mukherjee; Mainak Sengupta; Shyamal K Das; Kunal Ray
Journal:  Behav Brain Funct       Date:  2010-06-15       Impact factor: 3.759

10.  COMMD1 Promotes pVHL and O2-Independent Proteolysis of HIF-1alpha via HSP90/70.

Authors:  Bart van de Sluis; Arjan J Groot; Jeroen Vermeulen; Elsken van der Wall; Paul J van Diest; Cisca Wijmenga; Leo W Klomp; Marc Vooijs
Journal:  PLoS One       Date:  2009-10-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.